BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

JENBURKTPHARMACEUTICALS01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

JENBURKTPHARMACEUTICALS01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
23-May-2023	D	The Board of Directors at their meeting held on 23rd May, 2023 recommended a dividend of Rs.14.40 per equity share of Rs.10/- each. The Board of Directors of the Company, at their meeting held on 23rd May, 2023, fixed the book closure date starting from Thursday, 20th July, 2023 to Wednesday, 26th July, 2023 (both days inclusive) for the purpose of payment of dividend, as recommended in the same meeting. The Board has also, fixed the cut-off date as Wednesday, 19th July, 2023, for the purpose of determining the eligibility of Shareholders eligible for remote e-voting or e-voting during the 38th AGM, scheduled on Wednesday, 26th July, 2023.	19-Jul-2023
27-May-2022	D	The Board of directors at their meeting held on 27th May, 2022 recommended a dividend of Rs.12/- (120%) per Rs.10/- paid-up 4589378 equity shares of the Company.	21-Jul-2022
02-Jun-2021	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 02, 2021, inter alia, have recommended a dividend of Rs.10.20 (102%) per equity share of Rs.10/- each on 4589378 equity shares of the Company.	30-Aug-2021
06-Mar-2020	D	The Board of Directors of the Company have declared an interim dividend of Rs.8.10 on 4589378 equity shares of the Company.	18-Mar-2020
28-May-2019	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended a Final Dividend of Rs. 10.20 (102%) per equity share of Rs.10/- each on 4589378 equity shares of the Company.	22-Jul-2019
29-May-2018	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2018, inter alia, has transacted the following: - A Final Dividend of Rs. 6.00 (60%) per equity share of Rs. 10/- each has been recommended by the Board, on 4589378 equity shares of the Company. The total dividend, including interim dividend of Rs. 3/- per equity shares, is Rs. 9/- per equity shares of the Company for the financial year 2017-18.	23-Jul-2018
20-Mar-2018	D	Board of Directors of the Company at their meeting held today i.e. 20.03.2018 have declared the Interim Dividend of Rs.3.00 (i.e. 30%) per equity share.	27-Mar-2018
30-May-2017	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2017, inter alia, has: - A Dividend of Rs. 8.10 (81%) per equity share of Rs. 10/- each has been recommended by the Board.	21-Jul-2017
30-May-2016	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, has transacted the following: 1. A Final Dividend of Rs. 0.90 (9%) per equity share of Rs. 10/- each has been recommended by the Board.	19-Jul-2016
10-Mar-2016	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 10, 2016, have declared the Interim Dividend of Rs. 6.30 (i.e. 63%) per equity share of Rs. 10/- each for the financial year 2015-16. The interim Dividend shall be paid on or after March 28, 2016.	17-Mar-2016
21-May-2015	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2015, inter alia, have transacted the following : A Dividend of Rs.6.30 (63%) per equity share of Rs.10/- each has been recommended by the Board.	31-Aug-2015
30-May-2014	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has recommended a Dividend of Rs. 5.10 (51%) per equity share of Rs. 10/- each.	03-Sep-2014
30-May-2013	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has been recommended a Dividend of Rs. 4.20 (42%) per equity share of Rs. 10/- each. The dividend, if any, declared at the ensuing Annual General Meeting scheduled on July 31, 2013, will be paid on or after August 13, 2013.	18-Sep-2013
26-May-2012	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2012, inter alia, has recommended a dividend of Rs. 3.50 (35%) per equity share of Rs. 10/- each.	23-Jul-2012
27-Jun-2011	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 25, 2011, inter alia, has recommended a Dividend of Rs. 3.50 (35%) per equity share of Rs. 10/- each.	21-Jul-2011
28-May-2010	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2010, inter alia, has recommended a dividend of Rs. 3.00 (30%) per equity shares of Rs. 10/- each.	21-Jul-2010
23-Jun-2009	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 23, 2009, inter alia, has recommended a dividend of Rs 1.80 (18%) per equity share of Rs 10/- each.	23-Jul-2009
26-Jun-2008	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 24, 2008, inter alia, has recommended a dividend of 12.5% equity share of Rs 10/-.	23-Jul-2008
03-Jun-2007	D	Jenburkt Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 02, 2007, inter alia, has transacted the following: 1. Recommended a dividend of 12.5% per equity share of Rs 10/- each.	18-Jul-2007
22-Oct-2005	D	10% Dividend	10-Aug-2005
12-Apr-2024	BC	Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we hereby inform you about the Changes in Senior Management personne	12-Apr-2024
19-Jan-2024	BC	JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve the Standalone unaudited financia	06-Feb-2024
27-Oct-2023	BC	JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve unaudited financial results for t	07-Nov-2023
25-Jul-2023	BC	JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve standalone unaudited financial re	08-Aug-2023
23-May-2023	BC	The Board of Directors of the Company, at their meeting held on 23rd May, 2023, fixed the book closure date starting from Thursday, 20th July, 2023 to Wednesday, 26th July, 2023 (both days inclusive)	26-Jul-2023

Announcement Date23-May-2023

Ex Dividend Date19-Jul-2023

Dividend(%)144

Announcement Date27-May-2022

Ex Dividend Date21-Jul-2022

Dividend(%)120

Announcement Date02-Jun-2021

Ex Dividend Date30-Aug-2021

Dividend(%)102

Announcement Date06-Mar-2020

Ex Dividend Date18-Mar-2020

Dividend(%)81

Announcement Date28-May-2019

Ex Dividend Date22-Jul-2019

Dividend(%)102

Announcement Date29-May-2018

Ex Dividend Date23-Jul-2018

Dividend(%)60

Announcement Date20-Mar-2018

Ex Dividend Date27-Mar-2018

Dividend(%)30

Announcement Date30-May-2017

Ex Dividend Date21-Jul-2017

Dividend(%)81

Announcement Date30-May-2016

Ex Dividend Date19-Jul-2016

Dividend(%)9

Announcement Date10-Mar-2016

Ex Dividend Date17-Mar-2016

Dividend(%)63

Announcement Date21-May-2015

Ex Dividend Date31-Aug-2015

Dividend(%)63

Announcement Date30-May-2014

Ex Dividend Date03-Sep-2014

Dividend(%)51

Announcement Date30-May-2013

Ex Dividend Date18-Sep-2013

Dividend(%)42

Announcement Date26-May-2012

Ex Dividend Date23-Jul-2012

Dividend(%)35

Announcement Date27-Jun-2011

Ex Dividend Date21-Jul-2011

Dividend(%)35

Announcement Date28-May-2010

Ex Dividend Date21-Jul-2010

Dividend(%)30

Announcement Date23-Jun-2009

Ex Dividend Date23-Jul-2009

Dividend(%)18

Announcement Date26-Jun-2008

Ex Dividend Date23-Jul-2008

Dividend(%)12

Announcement Date03-Jun-2007

Ex Dividend Date18-Jul-2007

Dividend(%)12

Announcement Date22-Oct-2005

Ex Dividend Date10-Aug-2005

Dividend(%)10

No Rights has been declared by JENBURKTPHARMACEUTICALS

Book Closure

Record Date	Split Date	Purpose
12-Apr-2024	-	Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we hereby inform you about the Changes in Senior Management personne
06-Feb-2024	-	JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve the Standalone unaudited financia
07-Nov-2023	-	JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve unaudited financial results for t
08-Aug-2023	-	JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve standalone unaudited financial re
26-Jul-2023	-	The Board of Directors of the Company, at their meeting held on 23rd May, 2023, fixed the book closure date starting from Thursday, 20th July, 2023 to Wednesday, 26th July, 2023 (both days inclusive)

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Lupin Ltd ₹1,654.75(+7.10/0.43%)	1,654.75	+7.10	75,091.67	132.46	36.44	3.90
Ipca Laboratories Ltd ₹1,337.70(-13.30/-0.98%)	1,337.70	-13.30	34,275.44	90.72	62.23	5.52
J B Chemicals & Pharmaceuticals Ltd ₹1,889.90(+4.30/0.23%)	1,889.90	+4.30	29,263.53	81.31	57.83	10.91
Sanofi India Ltd ₹8,624.25(-53.50/-0.62%)	8,624.25	-53.50	19,984.86	59.90	33.85	19.68
IOL Chemicals & Pharmaceuticals Ltd ₹395.55(+3.25/0.83%)	395.55	+3.25	2,303.02	-4.21	13.36	1.45

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	35.66	38.29	29.18	35.20	34.57	35.85
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	35.66	38.29	29.18	35.20	34.57	35.85
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.35	1.10	1.04	1.26	1.46	1.26
Total Income	37.01	39.38	30.21	36.45	36.03	37.11
Total Expenditure	28.47	29.18	22.21	27.70	27.59	27.24
PBIDT	8.54	10.20	8.00	8.75	8.44	9.88
Interest	0.07	0.07	0.07	0.08	0.10	0.09
PBDT	8.47	10.13	7.93	8.67	8.34	9.78
Depreciation	0.63	0.59	0.50	0.59	0.58	0.54
Tax	2.50	2.57	2.00	1.56	2.50	2.50
Deferred Tax	-0.06	-0.35	0.06	0.16	-0.18	-0.13
Reported Profit After Tax	5.40	7.32	5.37	6.35	5.43	6.87
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	5.40	7.32	5.37	6.35	5.43	6.87

EPS (Unit Curr.)	12.25	16.59	12.17	13.92	11.84	14.96
EPS (Adj) (Unit Curr.)	12.25	16.59	12.17	13.92	11.84	14.96
Calculated EPS (Unit Curr.)	12.25	16.59	12.17	14.40	11.90	14.96
Calculated EPS (Adj) (Unit Curr.)	12.25	16.59	12.17	14.40	11.90	14.96
Calculated EPS (Ann.) (Unit Curr.)	48.98	66.36	48.66	57.59	47.61	59.84
Calculated EPS (Adj) (Ann.) (Unit Curr.)	48.98	66.36	48.66	57.59	47.61	59.84
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	4.41	4.41	4.41	4.41	4.57	4.59
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	23.95	26.64	27.42	24.86	24.41	27.56
PBDTM(%)	23.75	26.46	27.18	24.63	24.12	27.28
PATM(%)	15.14	19.12	18.40	18.04	15.71	19.16

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.41	4.59	4.59	4.59	4.59	4.59
Reserves Total	117.98	112.79	93.88	75.41	72.88	56.67
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	122.39	117.38	98.47	80.00	77.47	61.26
Secured Loans	2.44	5.81	3.71	0.00	0.00	0.24
Unsecured Loans	0.49	0.94	1.36	3.44	7.47	0.01
Total Debt	2.93	6.75	5.07	3.44	7.47	0.25
Total Liabilities	125.32	124.13	103.54	83.44	84.94	61.51
APPLICATION OF FUNDS :
Gross Block	33.99	33.47	31.97	31.31	26.89	25.69
Less : Accumulated Depreciation	23.54	22.07	21.42	19.58	17.30	16.12
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	10.45	11.40	10.55	11.73	9.59	9.57
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.96	0.21	0.38	0.12	0.99	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	11.18	7.96	6.75	4.07	5.38	5.42
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	8.34	9.89	7.58	10.90	9.83	6.80
Sundry Debtors	16.96	15.21	14.00	17.83	22.89	12.54
Cash and Bank	53.81	49.02	56.51	57.69	51.70	41.11
Loans and Advances	1.98	1.78	1.64	1.55	1.72	1.68
Total Current Assets	81.09	75.90	79.73	87.97	86.14	62.14
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	12.25	14.68	12.39	13.75	14.59	12.79
Provisions	0.59	0.34	1.47	2.61	0.55	0.27
Total Current Liabilities	12.84	15.01	13.87	16.37	15.14	13.07
Net Current Assets	68.26	60.89	65.87	71.60	71.00	49.07
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1.14	1.23	1.56	0.35	0.49	0.38
Deferred Tax Liability	1.43	1.71	1.64	0.58	0.12	0.50
Net Deferred Tax	-0.29	-0.48	-0.08	-0.23	0.37	-0.12
Total Assets	90.56	79.98	83.47	87.29	87.33	63.94
Contingent Liabilities	19.55	16.61	16.64	16.61	16.58	16.61

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	5.03	2.49	2.53	1.23	1.18
Net Cash from Operating Activities	17.05	9.27	19.45	15.02	12.99
Net Cash Used In Investing Activities	2.62	-1.20	-18.78	-2.88	-10.53
Net Cash Used In Financing Activities	-21.04	-5.53	-0.71	-10.83	-2.42
Net Inc./Dec In Cash And Cash Equivalents	-1.37	2.54	-0.04	1.31	0.04
Cash And Cash Equivalents At End Of The Year	3.66	5.03	2.49	2.53	1.23

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

47.23%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

52.77%

**Promoter pledged shareholding 47.23%

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 353.62 crores. It has reported a sales of Rs. 35.66 crores and a net profit of Rs. 5.4 crores for the quarter ended December 2018. The company management includes Ashish U Bhuta, Bharat V Bhate,Rameshchandra J Vora,Arun R Raskapurwala,Ashish R Shah,Ashish U Bhuta,Dilip H Bhuta,Hina Ravindra Mehta,Sumit Ajaybhai Thakkar (Jenburkt Pharmaceuticals Ltd) among others.

Chairman

Ashish U Bhuta

Registered office

Nirmala Apartment P B No 37396,93 Jayprakash Road Andheri(W),Mumbai,Maharashtra,400058

FAX :91-22-66943127

Background

Incorporation Year1985

Face Value₹10

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0